Current Month 2004
Article Features
  Affluent Women Less Likely to Suffer Anxiety after Breast Cancer Treatment
New Anti-Inflammatory Strategy for Cancer Therapy Identified
Cancer Burden Seen Even Many Years After Diagnosis
Researchers To Report on All Clinical Trial Results, Not Just Favorable Ones
Counseling for Breast Cancer Patients Boosts Immunity, Health Habits
The Promise of Personalized Medicine
Understanding How Fish Oil Protects Against Breast Cancer
New Gene Identified in Breast Cancer
Researchers Discover New Tumor-Fighting Ability in Herceptin
Intervention Studies That Use Cancer Patients from High Risk Clinics May be Subject to Bias
Novel Imaging Technique Shows Lymph Nodes, Metastases in Breast Cancer Without Surgery
Women Starting Mammography On Time But Failing to Follow Up
Women with Breast Cancer Detected by Mammography Screening Have Better Outcomes
Mammography Has Low Risk of Recall for False Positive Findings
Immediate Breast Reconstruction after Mastectomy Does Not Delay Chemotherapy
MRI Appears More Effective for Detecting Breast Cancer in Women with BRCA Gene Mutations
NCI Announces Major Commitment to Nanotechnology for Cancer Research
Postmenopausal Women at High Risk for Breast Cancer Needed for New Prevention Study
Race a Factor in Breast Reconstruction after Mastectomy
Mammaglobin-A Vaccination Has Potential As Breast Cancer Treatment
Bright Idea Could Doom Cancer and Viruses
Educating Young Women on Lifelong Breast Health


Compound in Vegetables Found to Block Late-Stage Breast Cancer Cell Growth

A well-known anti-cancer agent in certain vegetables has just had its reputation enhanced. The compound, in broccoli and other cruciferous vegetables, has been found to be effective in disrupting late stages of cell growth in breast cancer.

Keith Singletary and doctoral student Steven Jackson of the University of Illinois at Urbana-Champaign report their finding involving sulforaphane (SUL), which they say could ultimately be used to enhance the prevention and treatment of breast cancer, in the Journal of Nutrition.

Read More of the Main Article

Radiation after Lumpectomy May be Unnecessary for Many Older Women

Older women treated with tamoxifen after removal of early-stage breast cancer by lumpectomy may safely be able to avoid radiation therapy and its unpleasant side effects. Writing in the New England Journal of Medicine, investigators from several major cancer research groups report that adding radiation to post-surgical tamoxifen treatment of women age 70 or older does not improve survival, has minimal impact on the risk of local tumor recurrence and does not prevent the need for eventual mastectomy.

"If a patient does not need to have radiation therapy, her quality of life can improve significantly," says Kevin Hughes, MD, of the Massachusetts General Hospital (MGH) Cancer Center, who led the study. "By showing that radiation therapy has very little impact on outcome for these patients, we can help each woman and her physician decide on the right treatment."

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon